<DOC>
	<DOCNO>NCT00689143</DOCNO>
	<brief_summary>This exploratory study first study clinical program overall objective develop novel pharmaceutical therapy comprise local administration GM-CSF treatment periodontitis . The project hypothesis base GM-CSF 's antibacterial putative bone regeneration property . Periodontitis major cause tooth loss people 35 year age . An effective pharmacological treatment today lack actual therapy would represent new treatment option large patient group suffer disease .</brief_summary>
	<brief_title>A Safety/Tolerability Pharmakokinetic Study Sargramostim Administrated Gingiva</brief_title>
	<detailed_description>It suggest local administration GM-CSF gingival tissue next periodontal destruction may reduce infectious condition antibacterial effect via stimulation neutrophil phagocytosis bacteria , enhance functional activity monocytes granulocyte , well stimulation bone tissue recalcification .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<criteria>Healthy individual ( male female ) refer Dept Oral &amp; Maxillofacial surgery low wisdom tooth surgically extract ≥ 20 ≤ 40 year age Analysis result blood status within normal reference range Ability attend schedule visit evaluation procedure Women childbearing potential : use adequate method contraception avoid pregnancy throughout study Signed informed consent Any significant disease ( acute chronic ) medication concomitant oral manifestation opinion investigator would interfere safety evaluation Leukine . An active osseous infection periodontal infection , active mucosal lesion history acute necrotizing ulcerative gingivitis . Current use anticoagulant therapy within 10 day baseline Current use immunomodulating medication Current use corticosteroid ( Amendment 1 : topical use permit ) . Current use lithium . Use tobacco product nicotine replacement therapy Alcohol drug abuse HIV hepatitis infection Pregnancy lactation Participation another clinical study medicinal product time inclusion Lack suitability participation trial , reason , judge Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>